Cumulus News Archive, 2021

10 December, 2021

Driving digital transformation across the UK healthcare sector

Read more

12 November, 2021

Cumulus’ CSO appears at FT Pharma conference to discuss new dementia treatments

Read more

14 September, 2021

Cumulus Neuroscience Appoints Dr Ruth McKernan CBE as Chair

Read more

25 June, 2021

Frontiers in Psychiatry paper explores feasibility of at-home EEG assessment

Read more

17 June, 2021

Cumulus Neuroscience Appoints Dr Ian Campbell to Board of Directors

Read more

4 May, 2021

Cumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund

Read more

5 April, 2021

Cumulus Neuroscience receives £1.8m Biomedical Catalyst grant to expand CNS biomarker platform

Read more

1 March, 2021

Cumulus Neuroscience adds Winterlight Labs’ speech analytics technology to its integrated physiological and digital biomarker platform for CNS disorders

Read more

5 January, 2021

Cumulus Neuroscience licences P1vital Product’s facial expression recognition software for use in CNS trials

Read more